Please login to the form below

Not currently logged in
Email:
Password:

MSD forms pneumococcal partnership

MSD and Serum Institute of India have formed a partnership to develop a pneumococcal conjugate vaccine

MSD, known as Merck in the US and Canada, and Serum Institute of India are to work together to develop and commercialise a pneumococcal conjugate vaccine (PCV) for use in emerging and developing countries. 

The companies will form a product advisory committee to oversee the activities required to develop and seek approval for PCV and pursue World Health Organisation (WHO) prequalification. 

Under the terms of the agreement, Merck, through an affiliate, will receive specific rights to market PCV in certain designated territories and Serum will receive specific rights in other territories. Both companies will contribute to the development and manufacture of PCV. This collaboration does not impact the ongoing vaccine development programmes in both the organisations.

Julie L Gerberding, president of Merck Vaccines, said: "Working side by side with Serum gives us the best chance of developing and bringing a product to the market that will help to protect more babies and children.

"Expanding vaccine access to emerging and developing markets is a top priority and we feel strongly that this collaboration will be a giant step toward impacting the devastation of pneumococcal disease."

Financial details of the agreement have not been disclosed.

9th August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics